TB R&D Weekly Update: Marine Drug Discovery Symposium at the NYAS

The New York Academy of Sciences will be hosting a symposium entitled “New Frontiers in Marine Drug Discovery” on May 20, 2011.

This 1-day symposium will overview the current state of the art in Marine Biomedicine and its role in the context of the drug discovery process – from the perspectives of both academia (early stage discovery) and industry (therapy development).

Plenary presentations will showcase recent improvements in natural product chemistry and new technologies addressing previous challenges in the development of therapies from natural sources, with special emphasis on those obtained from marine species. Participants will also 1) overview the present landscape of marine–derived compounds either approved, being developed or in clinical trials for treating various malignancies, including cancer, neurological, infectious, cardiovascular, metabolic, and inflammatory diseases, and 2) explore the challenges, lessons and future directions learned from a few examples of pioneering efforts, failures, and successes in the translation of small molecules of natural marine origin into new therapies for disease.

Call for Poster Abstracts

The deadline for abstract submission is Friday, April 29, 2011. For complete abstract instructions, please send an e-mail to: Type the words “Abstract Information” in the subject line-there is no need to type a message. Instructions will be forwarded automatically. Any questions, please call 212.298.8632.

Additional TB R&D News:

Top 30 medicines to save mothers and children

TB still cause for concern in South East Asia: WHO

South Africa: The Success of Decentralising DR-TB Treatment

Association of mutation patterns in gyrA/B genes and ofloxacin resistance levels in Mycobacterium tuberculosis isolates from East China in 2009

More News
19 Mar 2024
For World TB Day 2024, the WGND is spotlighting a monumental achievement in TB drug research and development: the Global TB Drug Pipeline has never been bigger than it is today. The number of drug candidates being clinically evaluated for use in the treatment of adult pulmonary TB has surpassed...
3 Aug 2023
The Working Group on New TB Drugs, in collaboration with the New Diagnostics Working Group, Working Group on New Vaccines, FIND, IAVI, and TB Alliance, is co-hosting a New Tools Summit at the Marriot Champs Elysée Hotel in Paris, France on Tuesday, 14 November 2023. The WGND Annual Meeting will be...
23 Aug 2022
The PAN-TB collaboration announced initial plans for a Phase 2 clinical trial evaluating two novel drug regimens to treat Tuberculosis. Sponsored by the Bill and Melinda Gates Foundation, the PAN-TB, or “Project to Accelerate New Treatments for Tuberculosis”, collaboration brings together non-...